Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
BMC Infectious Diseases|March 4, 2018
Cost analysis of rapid diagnostics for drug-resistant tuberculosisErik J Groessl, Theodore G Ganiats, Naomi Hillery, et al.
The American Journal of Drug and Alcohol Abuse|July 13, 2012
HIV infection risk among injection drug users in a methadone maintenance treatment program, Taipei, Taiwan 2007-2010Yung-Feng Yen, Timothy C Rodwell, Muh-Yong Yen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 8, 2025
Cost-effectiveness of Targeted Next Generation Sequencing for TB drug-resistance testing as an alternative to the standard of care in South AfricaAlexandra de Nooy, Shaheed Vally Omar, Tom Ockhuisen, et al.
Antimicrobial Agents and Chemotherapy|June 27, 2022
Variants in Bedaquiline-Candidate-Resistance Genes: Prevalence in Bedaquiline-Naive Patients, Effect on MIC, and Association with Mycobacterium tuberculosis LineageEmmanuel Rivière, Lennert Verboven, Anzaan Dippenaar, et al.
The Journal of Infectious Diseases|October 9, 2019
Guidance for Studies Evaluating the Accuracy of Rapid Tuberculosis Drug-Susceptibility TestsSophia B Georghiou, Samuel G Schumacher, Timothy C Rodwell, et al.
Journal of Clinical Microbiology|May 27, 2016
Rapid Drug Susceptibility Testing of Drug-Resistant Mycobacterium tuberculosis Isolates Directly from Clinical Samples by Use of Amplicon Sequencing: a Proof-of-Concept StudyRebecca E Colman, Julia Anderson, Darrin Lemmer, et al.
The Lancet. Microbe|February 22, 2026
Bedaquiline resistance in patients with Xpert MTB/RIF Ultra-tested rifampicin-resistant tuberculosis in the Western Cape, South Africa: a prospective studyJanré Steyn, Jennifer Williams, Fahd Naufal, et al.
Frontiers in Immunology|December 5, 2022
Circulating mitochondrial cell-free DNA dynamics in patients with mycobacterial pulmonary infections: Potential for a novel biomarker of diseaseSheng-Wei Pan, Rehan R Syed, Donald G Catanzaro, et al.
PLOS Global Public Health|March 31, 2023
Updating the WHO target product profile for next-generation Mycobacterium tuberculosis drug susceptibility testing at peripheral centresEmily Lai-Ho MacLean, Paolo Miotto, Lice González Angulo, et al.
The Lancet. Infectious Diseases|November 1, 2024
Evaluating culture-free targeted next-generation sequencing for diagnosing drug-resistant tuberculosis: a multicentre clinical study of two end-to-end commercial workflowsRebecca E Colman, Marva Seifert, Andres De la Rossa, et al.
Pageof 8